371 related articles for article (PubMed ID: 31638682)
1. Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders: A Randomized Clinical Trial.
Reddihough DS; Marraffa C; Mouti A; O'Sullivan M; Lee KJ; Orsini F; Hazell P; Granich J; Whitehouse AJO; Wray J; Dossetor D; Santosh P; Silove N; Kohn M
JAMA; 2019 Oct; 322(16):1561-1569. PubMed ID: 31638682
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism.
Mouti A; Reddihough D; Marraffa C; Hazell P; Wray J; Lee K; Kohn M
Trials; 2014 Jun; 15():230. PubMed ID: 24934401
[TBL] [Abstract][Full Text] [Related]
3. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
King BH; Hollander E; Sikich L; McCracken JT; Scahill L; Bregman JD; Donnelly CL; Anagnostou E; Dukes K; Sullivan L; Hirtz D; Wagner A; Ritz L;
Arch Gen Psychiatry; 2009 Jun; 66(6):583-90. PubMed ID: 19487623
[TBL] [Abstract][Full Text] [Related]
4. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.
King BH; Dukes K; Donnelly CL; Sikich L; McCracken JT; Scahill L; Hollander E; Bregman JD; Anagnostou E; Robinson F; Sullivan L; Hirtz D
JAMA Pediatr; 2013 Nov; 167(11):1045-52. PubMed ID: 24061784
[TBL] [Abstract][Full Text] [Related]
5. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.
Hollander E; Soorya L; Chaplin W; Anagnostou E; Taylor BP; Ferretti CJ; Wasserman S; Swanson E; Settipani C
Am J Psychiatry; 2012 Mar; 169(3):292-9. PubMed ID: 22193531
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.
Geller DA; Hoog SL; Heiligenstein JH; Ricardi RK; Tamura R; Kluszynski S; Jacobson JG;
J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):773-9. PubMed ID: 11437015
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.
Liebowitz MR; Turner SM; Piacentini J; Beidel DC; Clarvit SR; Davies SO; Graae F; Jaffer M; Lin SH; Sallee FR; Schmidt AB; Simpson HB
J Am Acad Child Adolesc Psychiatry; 2002 Dec; 41(12):1431-8. PubMed ID: 12447029
[TBL] [Abstract][Full Text] [Related]
9. Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
Häge A; Banaschewski T; Buitelaar JK; Dijkhuizen RM; Franke B; Lythgoe DJ; Mechler K; Williams SC; Dittmann RW;
Trials; 2016 Mar; 17(1):141. PubMed ID: 26983548
[TBL] [Abstract][Full Text] [Related]
10. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
March JS; Biederman J; Wolkow R; Safferman A; Mardekian J; Cook EH; Cutler NR; Dominguez R; Ferguson J; Muller B; Riesenberg R; Rosenthal M; Sallee FR; Wagner KD; Steiner H
JAMA; 1998 Nov; 280(20):1752-6. PubMed ID: 9842950
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
[TBL] [Abstract][Full Text] [Related]
12. The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder.
Herscu P; Handen BL; Arnold LE; Snape MF; Bregman JD; Ginsberg L; Hendren R; Kolevzon A; Melmed R; Mintz M; Minshew N; Sikich L; Attalla A; King B; Owley T; Childress A; Chugani H; Frazier J; Cartwright C; Murphy T;
J Autism Dev Disord; 2020 Sep; 50(9):3233-3244. PubMed ID: 31267292
[TBL] [Abstract][Full Text] [Related]
13. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
Bergeron R; Ravindran AV; Chaput Y; Goldner E; Swinson R; van Ameringen MA; Austin C; Hadrava V
J Clin Psychopharmacol; 2002 Apr; 22(2):148-54. PubMed ID: 11910259
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
[TBL] [Abstract][Full Text] [Related]
15. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).
Alaghband-Rad J; Hakimshooshtary M
Eur Child Adolesc Psychiatry; 2009 Mar; 18(3):131-5. PubMed ID: 19190958
[TBL] [Abstract][Full Text] [Related]
17. Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial.
Aspvall K; Andersson E; Melin K; Norlin L; Eriksson V; Vigerland S; Jolstedt M; Silverberg-Mörse M; Wallin L; Sampaio F; Feldman I; Bottai M; Lenhard F; Mataix-Cols D; Serlachius E
JAMA; 2021 May; 325(18):1863-1873. PubMed ID: 33974020
[TBL] [Abstract][Full Text] [Related]
18. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.
Geller DA; Wagner KD; Emslie G; Murphy T; Carpenter DJ; Wetherhold E; Perera P; Machin A; Gardiner C
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1387-96. PubMed ID: 15502598
[TBL] [Abstract][Full Text] [Related]
19. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
Koran LM; Cain JW; Dominguez RA; Rush AJ; Thiemann S
Am J Psychiatry; 1996 Nov; 153(11):1450-4. PubMed ID: 8890679
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Williams K; Wheeler DM; Silove N; Hazell P
Cochrane Database Syst Rev; 2010 Aug; (8):CD004677. PubMed ID: 20687077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
